World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 17 October 2022
Main ID:  ISRCTN11278582
Date of registration: 29/05/2018
Prospective Registration: No
Primary sponsor: Regional Council in Kalmar County
Public title: Affect school as complementary treatment in eating disorders
Scientific title: Affect school as complementary treatment in eating disorders: A randomized controlled study
Date of first enrolment: 01/03/2018
Target sample size: 50
Recruitment status: Completed
URL:  https://www.isrctn.com/ISRCTN11278582
Study type:  Interventional
Study design:  A randomized controlled study. After informed consent has been signed, baseline measures are performed, after this the participants are randomised to either the intervention group together with their usual treatment or to TAU solely. (Treatment)  
Phase:  Not Applicable
Countries of recruitment
Sweden
Contacts
Name: Suzanne    Petersson
Address:  ABC, Kaggensgatan 42 s-392 32 Kalmar Sweden
Telephone: +46 480 84462
Email: suzannep@ltkalmar.se
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Eating disorder diagnosis
2. Swedish as spoken language
3. Aged =18 years

Exclusion criteria:
1. BMI <15 kg/m2
2. Acute state of starvation
3. Psychosis
4. Acute high level of suicidality


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Eating Disorders
Mental and Behavioural Disorders
Eating Disorders
Intervention(s)

Block-randomisation is performed by an independent researcher who is not a part of the project. Half of the participants will be randomized into the intervention Group, the Affect school, and keep their usual treatment at the clinic, and half of the participants will keep their treatment but will not receive the Affect school intervention. The Affect school is a group treatment with education and discussions on emotions. The treatment is based on a manual and consists of eight sessions during eight weeks (two hours per session).

Both treatment arms will be followed up directly after the end of the intervention, then after 6 and 12 months respectively. As there will be several rounds of the treatment (each lasting 8 weeks) the follow ups will be undertaken according this pattern until the last group (and control group) have done their 12 months follow up.
Primary Outcome(s)

1.Eating disorder symptoms using the Eating Disorder Examination Questionnaire (EDE Q),which is a self-assessment scale, symptoms are measured at baseline, after the intervention, 6 and 12 months after the end of the intervention.
2. Difficulties in Emotion Regulation Scale, brief version (DERS) with a self-assessment scale called Difficulties in Emotion Regulation Scale (DERS) at baseline, at the end of the intervention, 6 and 12 months after the end of the intervention
3. Alexithymia with the self-assessment scale Toronto Alemithymia Scale-20 (TAS-20) at baseline, after the intervention, 6 and 12 months after the end of the intervention.

The same measures and time intervals apply to the intervention and the control groups.
Secondary Outcome(s)

1. Body Mass Index (BMI) at the start of the intervention and after 12 months.
2. Eating disorder diagnoses at baseline, at 6 and 12 months after the end of the intervention

The same measures and time intervals apply to the intervention and the control groups.
Secondary ID(s)
531-31
Source(s) of Monetary Support
Fredrik och Ingrid Thurings Stiftelse, Sweden, Kalmar County Council
Secondary Sponsor(s)
Fredrik och Ingrid Thurings stiftelse
Ethics review
Status:
Approval date:
Contact:
The study was approved by the approved by the regional ethical review board of Linköping University, Faculty of Medicine, 13/02/2018, 2017/531-31
Results
Results available: Yes
Date Posted:
Date Completed: 30/04/2021
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history